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202Surgical vein graft preparation promotes cellular
dysfunction, oxidative stress, and intimal
hyperplasia in human saphenous vein
Michael J. Osgood, MD,a Kyle M. Hocking, BE,a Igor V. Voskresensky, MD,a Fan Dong Li, PhD,b
Padmini Komalavilas, PhD,a,c Joyce Cheung-Flynn, PhD,a and Colleen M. Brophy, MD,a,c Nashville, Tenn;
and Jinan Military District, China
Introduction: Human saphenous vein (HSV) is the most widely used bypass conduit for peripheral and coronary vascular
reconstructions. However, outcomes are limited by a high rate of intimal hyperplasia (IH). HSV undergoes a series of
ex vivo surgical manipulations prior to implantation, including hydrostatic distension, marking, and warm ischemia in
solution. We investigated the impact of surgical preparation on HSV cellular function and development of IH in organ
culture. We hypothesized that oxidative stress is a mediator of HSV dysfunction.
Methods: HSV was collected from patients undergoing vascular bypass before and after surgical preparation. Smooth
muscle and endothelial function were measured using a muscle bath. Endothelial preservation was assessed with
immunohistochemical staining. An organ culture model was used to investigate the inﬂuence of surgical preparation
injury on the development of IH. Superoxide levels were measured using a high-performance liquid chromatography-
based assay. The inﬂuence of oxidative stress on HSV physiologic responses was investigated by exposing HSV to
hydrogen peroxide (H2O2).
Results: Surgical vein graft preparation resulted in smooth muscle and endothelial dysfunction, endothelial denudation,
diminished endothelial nitric oxide synthase staining, development of increased IH, and increased levels of reactive oxygen
species. Experimental induction of oxidative stress in unmanipulated HSV by treatment with H2O2 promoted endothelial
dysfunction. Duration of storage time in solution did not contribute to smooth muscle or endothelial dysfunction.
Conclusions: Surgical vein graft preparation causes dysfunction of the smooth muscle and endothelium, endothelial denu-
dation, reduced endothelial nitric oxide synthase expression, and promotes IH in organ culture. Moreover, increased levels of
reactive oxygen species are produced and may promote further vein graft dysfunction. These results argue for less injurious
means of preparing HSV prior to autologous transplantation into the arterial circulation. (J Vasc Surg 2014;60:202-11.)
Clinical Relevance: Approximately 1,000,000 aortocoronary and peripheral vascular reconstructions are performed
annually using human saphenous vein grafts. However, outcomes from this procedure are limited by high rates of graft
failure. The leading cause of vein graft failure is intimal hyperplasia. A multifactorial process, intimal hyperplasia is
thought to arise at least in part due to vein graft injury. Signiﬁcant trauma occurs to the graft during surgical harvest and
subsequent preparation, signiﬁcantly impairing cellular function and increasing oxidative stress. Efforts to reduce early
vein graft injury during harvest and preparation may have the potential to reduce subsequent vein graft failure in patients.the Department of Surgery, Vanderbilt University Medical Center,
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://dx.doi.org/10.1016/j.jvs.2013.06.004Approximately 1,000,000 aortocoronary and periph-
eral vascular reconstructions are performed annually using
human saphenous vein (HSV). The leading cause of vein
graft failure is intimal hyperplasia (IH).1 This process leads
to pathologic narrowing of the vessel lumen, graft stenosis,
and ultimately graft failure.2 IH remains the primary factor
limiting the durability of vein bypass grafts and contributes
to signiﬁcant morbidity, reintervention, limb loss, myocar-
dial infarction, and death. While technical errors, poor
outﬂow, thrombosis, and vasospasm are the principle etiol-
ogies of vein graft failure in the immediate postoperative
period (<30 days), IH and atherosclerosis are the leading
causes of vein graft failure in the short-term (30 days to
2 years) and long-term (>2 years) time frames, respec-
tively.3 Two recent large phase III multicenter, random-
ized, double-blinded, placebo-controlled clinical trials
have examined outcomes in coronary artery bypass grafting
and peripheral vascular bypass grafting. The Project of Ex-
vivo Vein Graft Engineering via Transfection (PREVENT)
Fig 1. Steps in surgical vein graft preparation and sources of tissue
used in this investigation. Following human saphenous vein (HSV)
harvest, vein graft preparation is performed. Ex vivo manipulations
include hydrostatic distention to identify leaks and overcome
spasm, marking with a surgical skin marker for orientation
purposes, and repair of leaks. The conduit is then placed in
a storage solution at room temperature where it undergoes a vari-
able period of warm ischemia. These steps all precede eventual
surgical implantation in the arterial circulation. For this investiga-
tion, HSV obtained immediately following harvest (“unmanipu-
lated”; UM-HSV) was compared with HSV obtained following
surgical vein graft preparation (“after manipulation”; AM-HSV).
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following peripheral vascular bypass grafting.4 The per
patient vein graft failure rate after coronary artery bypass
grafting was 45% in the PREVENT IV trial at 12 to 18
months.5 These trials set a modern standard for benchmark
outcomes from these procedures.
Successive and additive levels of vein graft injury occur
during vein conduit harvest and preparation. These include
mechanical stretch,6 conduit distension using a hand-held
syringe for identiﬁcation of leaks and side branches,7
marking of the conduit using surgical skin markers for
purposes of orientation,8 and vein conduit storage in acidic
solutions.9 The surgical literature has focused primarily on
the histologic and morphologic changes occurring to the
vein graft following surgical harvest and preparation,
including disruption of the vasa vasorum,10 surgical trauma
to the endothelium,11 and tunica media.12 However, the
degree to which these morphologic changes impact the
cellular viability and physiology of the HSV graft has not
been well investigated. Moreover, the standard process of
vein graft preparation including distension, marking, and
warm ischemia in solution has never been validated or
demonstrated to adequately preserve tissue viability.
Oxidative stress is a well-known mechanism mediating
vascular injury in multiple cardiovascular diseases.13 The
production of reactive oxygen species becomes magniﬁed
and dysregulated in pathophysiologic states and serves as
a secondary mediator of injury. Oxidative stress has been
postulated to contribute to vein graft dysfunction,14 but
evidence of this is lacking in human tissue. Therefore, we
investigated the inﬂuence of surgical vein graft preparation
on cellular viability and HSV physiology, the role of
surgical vein graft preparation in the development of IH
in vitro, and the role of oxidative stress as a mechanistic
contributor to vein graft dysfunction in HSV.
METHODS
HSV procurement. HSV samples were obtained after
approval from the Institutional Review Boards of Vander-
bilt University Medical Center and the Tennessee Valley
Veterans Affairs Medical Center, Nashville, Tenn. HSV
segments were collected after obtaining informed consent
from patients undergoing coronary artery bypass grafting.
Method of vein harvest (open or endoscopic) and graft
preparation was at the discretion of the surgical team.
Vein segments were collected immediately following
surgical harvest (“unmanipulated” vein samples; UM)
and were used immediately following collection for exper-
iments described below. Additional vein segments were
collected again later after a series of manipulations,
including hydrostatic distention with a hand-held syringe,
dotted or continuous marking with a surgical skin marker,
and placement in heparinized plasmalyte (HP; 10 units
heparin/mL plasmalyte) at room temperature for storage
until implantation (“after manipulation” vein samples; AM;
Fig 1), and were used immediately prior to implantation for
the experiments described below. Veins were used for
experimentation within 15 minutes of collection. Whenopen harvest was employed, the vein was divided distally,
cannulated, and crystalloid was intermittently infused to aid
in side branch ligation. For all HSV used in this study, we
obtained paired UM/AM samples, except where speciﬁed.
All HSV used for the experiments described below was
stored in HP at room temperature until experimentation.
All AM-HSV segments procured for this study were small
pieces removed from either end of the conduits used for
revascularization and were collected at the time of arterial
implantation. Areas of HSV subjected to clamp or crush
injury were discarded. Therefore, all segments of AM-HSV
we obtained were intended for use as part of bypass
conduits and were obtained at the time of arterial
implantation. The particular anatomic portion of HSV that
was procured (ie, proximal vs distal) was, again, at the
discretion of the surgical team and was not recorded for
this study.
Collection of clinical demographic variables. Along
with prospective collection of HSV tissue, demographic
variables of the source patients were prospectively
collected, including age, gender, race, body mass index,
medical comorbidities, preoperative laboratory values,
preoperative medication regimen, and method of HSV
harvest.
Physiological measurement of HSV smooth muscle
functional viability. HSV samples were sectioned into
1-mm rings. These were weighed and their diameter was
measured. HSV rings were suspended in a muscle bath
containing a bicarbonate buffer as previously described.15
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HSV with potassium chloride (KCl), which causes
membrane depolarization and contraction of functionally
viable smooth muscle.16 Rings were then washed to
remove KCl and equilibrated in bicarbonate buffer for
30 minutes.6 The concentration of the physiologic agonist
phenylephrine (PE) that induces submaximal contractile
responses was determined by treating the tissue with
increasing doses (0.01, 0.1, and 1 mM) of PE. Contractile
response was deﬁned as stress ([105 Newtons (N)/m2] ¼
force (g)  0.0987/area, where area is equal to the wet
weight [(mg)/length (mm at maximal length)] divided by
1.055),17 which was calculated using the force (g) gener-
ated by the tissue. We have previously demonstrated
that the production of force of less than 0.025  105 N/m2
in response to KCl correlates with diminished cellular
viability as measured by the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide live/dead assay.6
Physiological measurement of HSV smooth
muscle-dependent vasorelaxation. HSV was prepared as
described above except that the endothelium was gently
mechanically denuded. Viable HSV was precontracted
with PE and treated with escalating doses of sodium nitro-
prusside (SNP) necessary to achieve measurable vasorelax-
ation (108 to 106 M).
Physiological measurement of HSV endothelial-
dependent vasorelaxation. HSV was prepared and tested
as described above except that the endothelium was
preserved. Viable HSV was precontracted with PE and
then exposed to carbachol (CCH; 5  107 M), an acetyl-
choline analog, and the maximal relaxation response was
determined.18
HSV immunohistochemical staining for CD31 and
endothelial nitric oxide synthase (eNOS). HSV segments
were ﬁxed in 10% formalin and sent to the Vanderbilt Trans-
lational Pathology Shared Resource for processing. Tissues
were dehydrated with ethanol, embedded in parafﬁn, and
immunostained using a Bond Max IHC stainer (Leica Bio-
systems GmbH, Nussloch, Germany). Heat-induced an-
tigen retrieval was performed using their Epitope Retrieval 2
solution (Leica Biosystems GmbH) for 20 minutes. Slides
were incubated with CD31 (NCL-CD31-1A10; Leica
Microsystems, Buffalo Grove, Ill) at 1:100 dilution or eNOS
(ab91205; Abcam, Inc, Cambridge, Mass) at 1:600 dilution
for one hour. The Bond Polymer Reﬁne detection system
(Leica Biosystems GmbH) was used for visualization. Slides
were then dehydrated, cleared, and coverslipped. The
degree of endothelial staining for eNOS and CD31 was
assessed using an Axiovert (Carl Zeiss SMT GmbH, Ober-
kochen, Germany) at 20 to 100 magniﬁcation. The
intensity of staining was assessed by a blinded observer using
a qualitative score from (1þ) to (4þ) based on the
proportion of vein circumference with visible staining:
(1þ), <25% vein circumference; (2þ), 25% to 49%; (3þ),
50% to 74%; and (4þ), 75% to 100%.
HSV physiologic measurements as a function of
storage time. In order to investigate whether storage time
had any inﬂuence on the physiology of UM vs AM-HSV,we measured physiology as a function of storage time.
UM-HSV was procured as described above, sectioned into
rings, and placed in HP at room temperature for 30
minutes, 1 hour, 2 hours, and 3 hours. At the end of
incubation, HSV rings were suspended in a muscle bath in
duplicate for measurement of contractile force, smooth
muscle-dependent relaxation, and endothelial-dependent
relaxation.
HSV organ culture. Additional UM-HSV and AM-
HSV rings (3 mm in length) were cut, placed in eight-
well chamber slides in duplicate, and maintained in
RPMI 1640 medium with 30% FBS, 1% L-glutamine, and
1% penicillin/streptomycin for 14 days at 37C/5% CO2 as
previously described.19 After 14 days, tissue was ﬁxed in
formalin, imbedded in parafﬁn, and histologic sections
were prepared and stained with Verhoeff-Van Gieson.
Four-quadrant measurements were made of intimal and
medial thickness of preculture and postculture rings by
a blinded observer and intimal-to-medial ratio was
calculated.
Measurement of reactive oxygen species in HSV.
UM-HSV and AM-HSV were divided into 1-mm rings and
immediately processed by the Vanderbilt Free Radical in
Medicine Core for measurement of reactive oxygen species.
Tissues were incubated for 30 minutes at 37C in 1 mL of
Krebs/HEPES buffer containing 50 mmol/L of dihy-
droethidium (DHE). Superoxide (O2
) was measured using
DHE and a high-performance liquid chromatography-
based assay.20 The reaction of DHE with O2
 generates
2-hydroxyethidium. The 2-hydroxyethidium peak on high-
performance liquid chromatography reﬂects the amount of
O2
 formed in the tissue during the incubation and is
expressed per milligram of protein.
Experimental induction of oxidative stress in
HSV. UM-HSV was cut into 1-mm rings and placed in
HP containing hydrogen peroxide (H2O2) concentrations
of 100 mM, 1 mM, and 10 mM for 1 hour at room
temperature. HSV physiological measurements were then
performed in the muscle bath as described above.
Data analysis. Data is reported as mean 6 standard
error of the mean unless indicated otherwise. Paired two-
tailed t-tests were conducted to assess the statistical
signiﬁcance of each experiment using GraphPad Prism
software (La Jolla, Calif). P value of #.05 was considered
statistically signiﬁcant.
RESULTS
HSV collection and patient demographic variables.
The demographic variables for the patients included in this
analysis are listed in Table I. The demographics are typical
for patients undergoing coronary revascularization. Unless
stated otherwise, all experiments were performed with
paired UM/AM samples from the same patients. Over half
of the paired UM/AM-HSV samples were harvested
endoscopically, and the remainder of the paired UM/AM-
HSV samples were harvested utilizing conventional open
harvest technique. Open vs endoscopic vein graft harvest
did not produce any signiﬁcant differences in the
Table I. Preoperative clinical demographics of patients
from whom HSV was procured for this study
Age, years (mean 6 SD) 64.2 6 11
Gender, male 78%
Body mass index (mean 6 SD) 30.0 6 8
Race: Caucasian/African American 90%/10%
Endoscopic vein harvest 57%
History of smoking 65%
Hypertension 91%
Number of antihypertensives (mean 6 SD) 1.9 6 1.1
Angiotensin-converting-enzyme inhibitor use 49%
Beta blocker use 68%
Antiplatelet drug use 85%
Diabetes mellitus 57%
Preoperative hemoglobin A1c (mean 6 SD) 6.7 6 1.2
Hyperlipidemia 83%
Statin use 72%
Left ventricular ejection fraction, mean 53%
Chronic kidney disease 57%
End stage renal disease, dialysis dependent 4%
Peripheral vascular disease 17%
HSV, Human saphenous vein; SD, standard deviation.
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Angioscopy or valvulotomy were not utilized on any of the
HSV collected for this study. Papaverine was not used
during vein graft preparation.
HSV smooth muscle functional viability. UM-HSV
generated signiﬁcantly greater contractile force (0.13 6
0.009  105 N/m2) compared with AM-HSV (0.05 6
0.006  105; n ¼ 47; P < .0001; Fig 2, A). All UM-HSV
generated force of 0.025  105 N/m2 or greater, and
therefore, all UM-HSV was functionally viable by our pre-
established criteria.6 Of AM-HSV, 35 of 47 samples (74%)
were viable. UM-HSV generated signiﬁcantly greater
contractile force in response to PE (0.08 6 0.008  105
N/m2) compared with AM-HSV (0.04 6 0.005  105;
n ¼ 41; P < .0001; Fig 2, B). These data suggest that
surgical vein graft preparation causes injury that compro-
mises smooth muscle viability.
HSV smooth muscle-dependent vasorelaxation.
UM-HSV generated signiﬁcantly greater smooth muscle-
dependent relaxation (62% 6 4%) compared with
AM-HSV (31% 6 4%; n ¼ 34; P < .0001; Fig 2, C). These
data further suggest that surgical vein graft preparation
causes injury that compromises smooth muscle viability.
HSV endothelial-dependent vasorelaxation. UM-
HSV generated signiﬁcantly greater endothelial-dependent
relaxation (21% 6 3%) compared with AM-HSV (1% 6
2%; n ¼ 36; P < .0001; Fig 2, D). These data suggest that
surgical vein graft preparation causes injury that compro-
mises endothelial viability. Given that that endothelium is
the most fragile tissue component in HSV, these ﬁndings are
not unexpected, and argue for less injurious means of
surgical vein graft preparation in order to preserve this fragile
monolayer.
Immunohistochemical staining for eNOS and
CD31. We observed 3þ or 4þ CD31 staining in UM-
HSV (Table II). Surgical vein graft preparation was asso-
ciated with diminished CD31 staining in eight of 11samples of AM-HSV; endothelial coverage remained un-
changed in the remaining three of 11 samples after surgical
vein graft preparation. We observed more variability in UM-
HSV eNOS staining. Among UM-HSV samples, nine of 11
had 3þ or 4þ eNOS staining, and two of 11 had 1þ or 2þ
eNOS staining. Surgical vein graft preparation was associ-
ated with diminished eNOS staining in nine of 11 samples
and this was more pronounced than loss of CD31 staining:
two of 11 AM-HSV samples had 3þ staining; three of 11
samples had 2þ staining, and the remaining six of 11 had
1þ staining. Representative photomicrographs are illus-
trated in Fig 3. These data suggest that the diminished
endothelial viability observed following surgical vein graft
preparation results in part from endothelial denudation, and
furthermore from loss of eNOS.
HSV physiologic measurements as a function of
storage time. We measured physiologic parameters in
UM-HSV samples obtained from six patients. Duration
of vein graft storage for up to 3 hours at room temperature
in HP did not signiﬁcantly impair or improve the physio-
logic variables tested (Fig 4). There was no signiﬁcant
change in contractile response to KCl (n ¼ 6; P ¼ NS;
Fig 4, A), contractile response to PE (n ¼ 6; P ¼ NS;
Fig 4, B), SNP-induced smooth muscle-dependent
relaxation (n ¼ 6; P ¼ NS; Fig 4, C), or CCH-induced
endothelial-dependent relaxation (n ¼ 6; P ¼ NS; Fig 4,
D). These data suggest that the duration of time in
a physiologic storage solution does not cause HSV
dysfunction. Therefore, it must be the other components of
surgical vein graft preparation e distension and marking e
that contribute to vein graft dysfunction. These data
suggest that the vein graft dysfunction we observed in
AM-HSV was not due to the additional storage time in HP.
HSV organ culture. After 2 weeks in organ culture,
we observed an increase in intimal thickness of 22.81 6
18.77 mm in UM-HSV, and intimal/medial ratio
increased by 22% 6 27%. We observed an increase in
intimal thickness by 38.53 6 26.48 mm in AM-HSV, and
intimal/medial ratio increased by 50% 6 37%. Compared
with UM-HSV, AM-HSV developed a 69% increase in
intimal thickness (n ¼ 11; P ¼ .043; Fig 5, A), and a 122%
increase in intimal/medial ratio (n ¼ 11; P ¼ .015;
Fig 5, B). These observations demonstrate that surgical
vein graft preparation causes injury beyond that induced
by harvest alone and that is sufﬁcient to promote neo-
intimal growth.
Measurement of reactive oxygen species in HSV.
Levels of 2-hydroxyethidium in UM-HSV were 227.6 6
40.44 pmol/mg protein vs 382.5 6 43.07 in AM-HSV
(n ¼ 4; P ¼ .03; Fig 6), indicating increased generation
of reactive oxygen species after surgical vein graft prepa-
ration. These observations demonstrate that surgical vein
graft preparation causes additional reactive oxygen species
generation beyond that induced by harvest alone.
Experimental induction of oxidative stress in
HSV. We performed these experiments in UM-HSV
samples obtained from six patients. One hour treatment
of UM-HSV with H2O2 resulted in signiﬁcant blunting
Fig 2. Physiologic measurements of human saphenous vein (HSV) smooth muscle and endothelial function before and
after surgical vein graft preparation. Physiologic responses are signiﬁcantly impaired in HSV obtained after manipulation
(AM) compared with paired samples of unmanipulated (UM)-HSV; these include contractile response to potassium
chloride (KCl; n ¼ 47; P < .0001; A), contractile response to phenylephrine (PE; n ¼ 41; P < .0001; B), smooth
muscle-dependent relaxation in response to sodium nitroprusside (SNP; n ¼ 34; P < .0001; C), and HSV endothelial
function in response to carbachol (CCH; n ¼ 36; P < .0001; D). *P < .05; **P < .01; and ***P < .001.
Table II. Immunohistochemical staining for eNOS and
CD31 in HSV obtained unmanipulated and after surgical
manipulation
HSV
UM-HSV
eNOS
staining
AM-HSV
eNOS
staining
UM-HSV
CD31
staining
AM-HSV
CD31
staining
1 þþþ þþþ þþþ þþþþ
2 þþ þ þþþþ þþþþ
3 þ þ þþþ þþ
4 þþþþ þþþ þþþþ þþþþ
5 þþþ þþ þþþþ þþþ
6 þþþþ þþ þþþþ þþ
7 þþþ þþ þþþþ þþþ
8 þþþ þ þþþþ þþ
9 þþþ þ þþþþ þþ
10 þþþ þ þþþþ þþ
11 þþþþ þ þþþþ þþþ
AM-HSV, Human saphenous vein after surgical manipulation; eNOS,
endothelial nitric oxide synthase; HSV, human saphenous vein; UM-HSV,
unmanipulated human saphenous vein.
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of 1 mM and 10 mM, but not at 100 mM (Fig 7).
Endothelial-dependent relaxation in UM-HSV was 27% 6
9% in comparison with 9% 6 5% in UM-HSV treated with
1 mM H2O2 (n ¼ 6; P ¼ .04) and 10% 6 4% in UM-HSV
treated with 10 mM H2O2 (n ¼ 5; P ¼ .03). These datademonstrate that reactive oxygen species can cause
endothelial dysfunction in HSV. Therefore, the presence
of increased reactive oxygen species, such as that gener-
ated secondary to surgical vein graft preparation, serves as
a secondary mediator of vein graft dysfunction.DISCUSSION
HSV is harvested, prepared, stored, and then reim-
planted as a conduit to bypass arterial stenoses and occlu-
sions. Therefore, HSV is an autotransplanted organ, but
is not widely considered or treated as such. Surgical vein
graft preparation causes successive injury at multiple levels
prior to arterial implantation (Fig 1). Vein graft harvest is
injurious secondary to hypoxia, stretch, and traction
injury.6 After harvest, ex vivo vein graft preparation is per-
formed on the “back table.” While methods of vein graft
preparation remain surgeon-dependent, most distend the
conduit with a hand-held syringe in order to identify leaks
and overcome spasm. We have measured intraluminal pres-
sures generated during gentle distension, and these
uniformly exceed 750 mmHg (data not shown), regardless
of syringe size or perceived force placed on the syringe
plunger. Conduit distension causes signiﬁcant morphologic
changes, including endothelial denudation and smooth
muscle damage.7,21 Additionally, most surgeons mark the
vein graft for orientation using a sterile surgical marking
Fig 3. Immunohistochemical staining of human saphenous vein (HSV) for endothelial nitric oxide synthase (eNOS)
and CD31. Unmanipulated HSV (UM-HSV) exhibits continuous (4þ) eNOS and CD31 staining. HSV obtained after
surgical manipulation (AM-HSV) exhibits near absence of eNOS staining (1þ) and patchy loss of endothelial coverage
by CD31 staining (2þ). Photomicrographs are representative of 11 HSV samples. The scale bar represents 100 mm.
Fig 4. Human saphenous vein (HSV) physiological measurements as a function of warm ischemia time in heparinized
plasmalyte. Duration of warm ischemia for up to 3 hours does not inﬂuence smooth muscle contractile response to
potassium chloride (KCl; n ¼ 6; P ¼NS; A), smooth muscle contractile response to phenylephrine (PE; n ¼ 6; P ¼NS;
B), smooth muscle-dependent relaxation in response to sodium nitroprusside (SNP; n ¼ 6; P ¼ NS; C), or endothelial-
dependent relaxation in response to carbachol (CCH; n ¼ 6; P ¼ NS; D).
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Fig 5. Surgical vein graft preparation promotes development of
intimal hyperplasia (IH) in organ culture. A, The increase in
intimal thickness (mm) is signiﬁcantly greater in human saphenous
vein (HSV) obtained after surgical manipulation (AM) compared
with HSV obtained unmanipulated (UM) after 2 weeks in organ
culture (n ¼ 11; P ¼ .043). B, The percent increase in intimal to
medial ratio (I/M ratio) is signiﬁcantly greater in AM-HSV
compared with UM-HSV (n ¼ 11; P ¼ .015). *P < .05; **P <
.01; and ***P < .001.
Fig 6. The generation of reactive oxygen species in human
saphenous vein (HSV) is increased after undergoing sur-
gical vein graft preparation. Levels of reactive oxygen species were
assessed by measuring by the conversion of dihydroxyethidium
(DHE) to 2-hydroxyethidium. Levels of 2-hydroxyethidium were
signiﬁcantly greater in HSV obtained after ex vivo surgical vein
graft preparation injury compared with HSV immediately
following surgical vein graft harvest (n ¼ 4; P ¼ .03). *P < .05;
**P < .01; and ***P < .001. AM, After surgical manipulation;
UM, unmanipulated.
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strated that this common practice causes smooth muscle
and endothelial dysfunction secondary to toxic compo-
nents in the ink, including isopropyl alcohol (a solvent).8
Isopropyl alcohol is converted to acetone in vivo,22 which
increases oxidative stress by causing generation of reactive
oxygen species.23 Finally, the conduit is placed in a storage
solution for a variable duration. Normal saline is
a commonly utilized storage solution and is an acidic,
non-buffered solution with pH <6.0. Despite the non-
physiologic properties of this storage solution, normal
saline was utilized by 40% of centers (JH Alexander, MD,
unpublished data, 2013) in the PREVENT IV trial.5
Vein preparation techniques have yet to be scientiﬁcally
validated despite their widespread application.
Our results indicate that surgical vein graft preparation
causes signiﬁcant cellular dysfunction of the two prin-
ciple HSV cell types: smooth muscle and endothelium
(Fig 2, A-D). We have previously demonstrated that theproduction of force of less than 0.025  105 N/m2 in
response to KCl correlates with diminished cellular viability
as measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide live/dead assay.6 AM-HSV
produced signiﬁcantly diminished contractile force in re-
sponse to KCl (Fig 2, A), and PE (Fig 2, B). Smooth
muscle-dependent vasorelaxation in response to SNP
(Fig 2, C) was also diminished. Therefore, surgical vein graft
preparation causes additional vascular smooth muscle injury
beyond that incurred during surgical vein graft harvest
alone. To our knowledge, smooth muscle dysfunction has
not been demonstrated to occur in HSV grafts this early
ex vivo. These ﬁndings implicate surgical vein graft prepara-
tion as an important mediator of vein graft dysfunction.
The injury of potentially greatest consequence to the
long-term success of the bypass conduit is the loss of endo-
thelial function following surgical vein graft preparation
(Fig 2, D). We observed a contractile response to CCH
rather than relaxation in many of the AM-HSV samples.
Acetylcholine (and its analog, CCH) act on vascular
smooth muscle to cause vasoconstriction in tissue with
endothelial injury or loss.24 These measurements of dimin-
ished to absent endothelial function correlated with loss of
endothelial coverage on immunohistochemical staining for
CD31, with superimposed and more pronounced loss of
eNOS staining (Table II; Fig 3). These results suggest
that, while harvest leads to mild endothelial denudation
and loss of eNOS, these insults are magniﬁed following
ex vivo surgical vein graft preparation. A viable and intact
endothelium serves multiple protective roles. Nitric oxide
released by the endothelium promotes vasodilation and
prevents platelet adhesion and thrombosis. In contrast,
dysfunctional endothelium exerts prothrombotic proper-
ties25 and allows attachment of circulating platelets and
Fig 7. Experimental induction of oxidative stress causes endo-
thelial dysfunction in human saphenous vein (HSV). Compared
with unmanipulated (UM)-HSV, 1-hour treatment of UM-HSV
with hydrogen peroxide (H2O2) caused a signiﬁcant decline in
endothelial-dependent relaxation when exposed to 1 mM H2O2
(n ¼ 6; P ¼ .04) and 10 mM H2O2 (n ¼ 5; P ¼ .03). *P < .05;
**P < .01; and ***P < .001.
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development of the hyperplastic lesion.26 Endothelial
denudation therefore increases the risk of thrombosis in
the immediate postoperative period (<30 days), and may
initiate further cascades of vascular injury and damage,
leading to the development of IH in the short- and long-
term lifespan of the conduit.
Surgically harvested HSV (UM-HSV) that does not
undergo ex vivo surgical vein graft preparation exhibits
preservation of physiologic function for up to 3 hours of
storage in HP (10 U/mL) at room temperature (Fig 4).
We have identiﬁed HP as a buffered physiologic storage
solution that is superior to most other commonly utilizedstorage solutions for preservation of vein graft physiology
(data not shown), and this solution has been universally
adopted at our institution. These data demonstrate that
the additional storage time in HP to which the AM-HSV
segments were subjected in the course of our experimental
design did not contribute to physiologic dysfunction. This
suggests that the other manipulations occurring during this
period, such as hydrostatic distention and marking, are the
primary factors leading to smooth muscle and endothelial
dysfunction (Fig 2, A-D).
Injury incurred during surgical vein graft preparation is
a sufﬁcient stimulus for the promotion of IH in organ
culture, a well-validated in vitro model that replicates the
smooth muscle proliferation, migration, and extracellular
matrix deposition occurring in IH.19,27 We observed
a signiﬁcant increase in both intimal thickness and
intimal/medial ratio in HSV subjected to surgical vein graft
preparation (Fig 5). These data support the hypothesis that
early vein graft injury is an important stimulus leading to
IH. Importantly, this injury response can occur in the
absence of the turbulent and pulsatile hemodynamic alter-
ations associated with placement of a venous graft in arte-
rial circulation and in the absence of growth factors
released from circulating leukocytes and platelets, further
implicating pre-existing tissue injury as an inciting agent
in this process.
Our data indicate that cellular vein graft dysfunction is
mediated in part by oxidative stress. Levels of reactive
oxygen species nearly doubled in response to surgical
vein graft preparation (Fig 6). Moreover, experimentally
induced oxidative stress is a secondary mediator of endo-
thelial dysfunction in UM-HSV (Fig 7). Therefore, reactive
oxygen species are generated during vascular injury and
serve as secondary mediators of tissue injury, particularly
involving the endothelium.13 Even brief exposure to reac-
tive oxygen species has been demonstrated to stimulate
vascular smooth muscle cell proliferation in cultured cell
lines persisting well beyond the time of exposure.28 The
nicotinamide adenine dinucleotide phosphate oxidases are
the most important source for superoxide production and
they are activated by vascular injury and hypoxia.29,30
Oxidative stress enhances endothelial permeability and
promotes leukocyte attachment.13 Binding and activation
of neutrophils causes superoxide generation as part of the
respiratory burst.31 Superoxide production can initiate
a cascade of other reactive oxygen species (H2O2, hydroxyl
radicals, and peroxynitrite), which indiscriminately react
with and oxidize lipids, proteins, and DNA in the vicinity
and cause cellular damage and death.13,30 Reactive oxygen
species further react with and deplete NO, forming perox-
ynitrite.30 Therefore, oxidative stress is a plausible mecha-
nistic contributor to the near-complete loss of measurable
endothelial function (Fig 2, D) in HSV subjected to
surgical vein graft preparation.
While oxidative stress has been implicated in the path-
ogenesis of multiple cardiovascular diseases, it remains to
be demonstrated whether this contributes to vein graft
dysfunction in human tissue. Our data demonstrate
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early following surgical vein graft preparation; these reac-
tive oxygen species cause secondary injury to the vein
graft. Reactive oxygen species have been demonstrated
to initiate cellular responses with long-lasting effects per-
sisting beyond the time of exposure. For example, it has
been shown that very brief exposure to reactive oxygen
species lasting only 10 minutes is a sufﬁcient stimulus for
vascular smooth muscle proliferation in cultured cell
lines.28 It is not known yet whether avoiding vein graft
injury alone is sufﬁcient to prevent reactive oxygen species
generation, or whether antioxidant agents have thera-
peutic efﬁcacy. We have demonstrated that University of
Wisconsin organ preservation solution (which contains
the antioxidant glutathione) preserves vascular smooth
muscle function signiﬁcantly better than plasmalyte alone
(data not shown). Furthermore, preliminary proteomics
data point to a possible role of vascular smooth muscle
apoptosis in vein graft failure. Whether this process is
related to reactive oxygen species production is an area
of future investigation.
Based on these data, the following recommendations
should be considered. Conduit distention must be gentle
and pressures must be limited to physiologic levels when
possible. A simple but effective method for achieving this
is to perform the proximal arterial anastomosis ﬁrst, and
then to revascularize and distend the conduit using arterial
blood inﬂow. This method has the advantages of limiting
conduit pressures to systemic arterial blood pressures, and
shortening the period of “warm ischemia” during which
the vein is otherwise stored at room temperature in hypoxic
conditions. Marking the vein graft with surgical skin
marking pens should be avoided. The toxic components
in these pens cause signiﬁcant vein graft dysfunction.
When it is mandatory to mark the conduit (ie, during
tunneling so as to avoid twisting), we urge clinicians to
consider interrupted rather than continuous marking. A
buffered physiologic storage solution such as plasmalyte,
University of Wisconsin solution, or heparinized blood
should be used to store the conduit. Saline should be
avoided as a storage solution given its acidic and non-
buffered properties.
This study has several limitations. First, collection of
human tissue from different surgical teams introduced vari-
ability in the way the tissue was handled prior to experi-
mentation. However, the advantage of this approach is
that the AM-HSV segments obtained were sections from
the actual vein grafts used to revascularize patients, and
we obtained the tissue for experimentation immediately
prior to arterial implantation. In addition, our data
regarding IH was derived from an organ culture model
possessing limitations, including the absence of hemody-
namic alterations occurring in arterial circulation and the
absence of circulating leukocytes and other circulating
blood components that may modulate the development
of IH. Future areas of investigation include further mech-
anistic work into the means by which reactive oxygen
species induce vein graft failure, and also to investigatewhether reactive oxygen species generation can be avoided
using antioxidants or inhibitors of the nicotinamide
adenine dinucleotide phosphate oxidases.
CONCLUSIONS
In summary, surgical vein graft preparation causes endo-
thelial and smooth muscle dysfunction, diminished smooth
muscle viability, production of reactive oxygen species, and
IH. These results collectively argue for less injurious means
of surgical vein graft preparation. The ex vivo component
of vein graft preparation provides a unique therapeutic
window for delivery of compounds, antioxidants, or drugs
directly to the vein graft to prevent cellular dysfunction
and injury. Preservation of cellular viability in transplanted
organs is achieved in physiologic buffered storage solutions
with antioxidants. Since vein grafts are autotransplanted
organs, improved HSV preservation should be the focus of
future practices of surgical vein graft preparation in order
to enhance vein graft function and patency.
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